Recently, we have seen a wave of breakthroughs and approvals in the antibody-drug conjugates space. Keeping pace with the field's rapid advancements, the World ADC Event Series from Hanson Wade continues to provide unrivalled industry-focused insight and connections to accelerate the delivery of viable and life-changing therapeutics to oncology patients.
We share a common belief with the industry - that the potential of antibody-drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.
Get a comprehensive overview of the upcoming events within the World ADC Series below. If you have any questions, get in touch at adc@hansonwade.com.
From January to December: Upcoming Events in the World ADC Series
Trailblazing Innovation & Collaborations in ADC Drug Development in Asia
June 2025 | South Korea
The World's Definitive Antibody-Drug Conjugate Event Dedicated to Maximizing the Clinical Therapeutic Index of Your ADC
November 2024 | San Diego, CA
Stay informed about all the upcoming events and products designed to guarantee your success in the ADC field by
signing up here
Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavors more informed and more robust.